DRG International, founded in 1970 in the USA, is a multinational specialty clinical diagnostics and medical equipment developer and manufacturer with distributors in over 110 countries. The DRG Group focuses on high technology medical specialty areas particularly Immunology, Iron Metabolism and Oncology among others.
DRG ELISA Kits compete effectively in both price and performance in all major diagnostics and R&D markets worldwide. Our major product line covers the full range of hormones used in Gynecology and Obstetrics, Salivary tests, as well as Endocrinology, Diabetes, Infectious Diseases and Tumor Markers for diagnostic and R&D purposes.
DRG® is pleased to introduce its newest ELISA research kits for hypertensive disease, Aldosterone (EIA-5298) and Active Renin (EIA-5125), and Anti-Amyloid Beta Auto-Ab (EIA-5099) and Amyloid beta (1-40) (EIA-5231) for Alzheimer s Disease research. Also available is the NEW Hepcidin-25 bioactive ELISA (EIA-5258) for Iron Metabolism (U.S. Patents: 7,320,894, 7,411,048 & 7,998,691) and 25-OH Vitamin D ELISA (EIA-5396) for Vitamin D deficiency.
INTRODUCING: The NEW DRG:Hybrid XL FULLY AUTOMATED IMMUNOASSAYS & CLINICAL CHEMISTRY ANALYZER